Stopping Anafranil (clomipramine) suddenly can trigger withdrawal. The fix is easy to say and harder to do alone. Taper slowly, with a prescriber watching. Clomipramine is a tricyclic antidepressant approved for obsessive-compulsive disorder, and abrupt discontinuation can cause dizziness, nausea, headache, and sleep problems. What follows is what withdrawal feels like, how long it tends to last, and how detox and treatment actually work.
Anafranil withdrawal happens because your body adapts to clomipramine over weeks of daily use, then reacts when the drug leaves. That reaction has a name clinicians use, antidepressant discontinuation syndrome, and it shows up across a drug class that a huge share of the country relies on: roughly 12.7% of Americans aged 12 and over took an antidepressant in a recent four-year stretch, a quarter of them for 10 years or longer, which tells you two plain things at once, that staying on these medications for a long time is ordinary, and that coming off them is a step many people eventually face and almost no one should improvise.
Clomipramine is a tricyclic antidepressant, approved to treat obsessions and compulsions in OCD. It isn’t a federally controlled substance.
One rule sits above the rest. Don’t stop on your own.
Anafranil causes physical dependence, not addiction. Those two words get swapped constantly, and the difference is the whole point here, because dependence just means your body adapted to a medication and protests when it’s gone—and this is true even if you’ve taken every dose exactly as prescribed—while addiction means compulsive use and drug-seeking that continues despite real harm. Clomipramine has no evidence for drug-seeking behavior, aside from a single unusual case report involving someone with a history of multiple drug dependencies. Feeling withdrawal when you stop is expected biology, not a moral failing and not a substance use disorder.
Discontinuation symptoms affect roughly 15% of people who stop an antidepressant. Prescribers plan the exit for that reason.
Most Anafranil withdrawal symptoms are physical and flu-like, though sleep and mood usually take a hit too. After abrupt discontinuation, people report dizziness, nausea, vomiting, headache, malaise, sleep disturbance, hyperthermia, and irritability, sometimes alongside a worsening of the very psychiatric symptoms the drug was treating, a list that maps closely onto the dizziness, irritability, headache, vivid dreams, and flu-like aches documented when the drug is stopped quickly. None of it is pleasant. Most of it is temporary.
Here’s how the symptoms tend to cluster:
Some people describe brief electric-shock sensations, often called “brain zaps.” These aren’t named in the clomipramine label, so treat them as commonly reported rather than formally cataloged for this drug. Worth mentioning to your prescriber if they show up.
There’s no official hour-by-hour timeline for clomipramine, but the pattern is well described, and two published case reports make it concrete: a 45-year-old man developed a flu-like syndrome of headache, muscle aches, weakness, and fatigue plus nervousness and insomnia after abruptly stopping 75 mg a day, then cleared on his own after three days, while a 47-year-old woman hit severe insomnia, anxiety, and agitation after stopping a low 25 mg dose, which together sketch the same arc most people travel, symptoms within days of stopping, a rough patch, then a fade as the body recalibrates, the whole thing usually settling inside one to two weeks.
| Phase | What people often report |
|---|---|
| First few days |
|
| First one to two weeks |
|
| Beyond two weeks |
|
Timing varies by person, dose, and how long you took the drug. Restarting the medication and then tapering more slowly often settles the symptoms, which is exactly why a supervised plan beats quitting outright.
Coming off Anafranil is safer with support. Search for treatment that fits your needs and your coverage.
Find Treatment OptionsQuitting Anafranil cold turkey is the main thing to avoid, because abrupt discontinuation is what drives the worst symptoms, and the recommendation is to taper the dose gradually with careful monitoring.
There’s a second danger, and it’s the one that scares people for good reason. Stopping can bring back the depression or OCD the drug was holding in check, and a sudden low mood carries its own weight. Withdrawal can also masquerade as an ordinary flu and get treated the wrong way, which only delays real help. Sorting a genuine relapse from short-term withdrawal is a known clinical challenge, and the case reports stress exactly that distinction.
Talk to your prescriber before you change anything. An “as prescribed” dependence still needs a gradual plan.
The safest way off Anafranil is a slow, prescriber-led taper, not a hard stop. One approach clinicians use is to reduce the dose by 50% every three days down to the lowest 25 mg dose, then stop, though your prescriber may go slower, especially after long-term use or if symptoms flare.
Here’s how a supervised taper usually runs:
No FDA-approved medication treats antidepressant discontinuation syndrome directly. Mild symptoms get supportive care, the way you’d handle a passing flu. The taper exists to keep those symptoms small in the first place.
For most people, coming off Anafranil is an outpatient process guided by the prescriber who wrote the script. Medically supervised detox means a clinician oversees the taper, tracks symptoms, and adjusts the plan instead of leaving you to manage it alone, and because clomipramine usually treats OCD or depression, stopping it almost always means lining up the next layer of mental health care at the same time, so the timing of the taper and the timing of that follow-on treatment have to be planned together rather than handed off separately.
Care comes in levels, and the right one depends on your symptoms and your support at home:
The right fit balances safety with daily life. That’s the heart of Reach Recovere’s Find-and-Fund approach: first find care that matches your needs, then sort out how to pay for it.
Start with the prescriber who manages your clomipramine, then widen the search if you need more support. A few questions cut through the noise when you compare programs: Does a medical team oversee the taper? Can they treat co-occurring OCD or depression? Do they take your insurance, and what will you owe?
You don’t have to make those calls blind. Reach Recovere is a nonprofit that helps you find treatment and work out how to pay for it. Our treatment search lets you compare options without a sales pitch.
Clomipramine carries the FDA’s most serious warning, a boxed warning, for an increased risk of suicidal thoughts and behavior in children, teens, and young adults up to age 24, with risk rising early in treatment and whenever the dose moves, up or down. A taper is a dose change. That’s one more reason to have a clinician watching closely while you come off.
The same warning doesn’t show that increased risk in adults over 24, and risk is lower still in adults 65 and older, but anyone of any age starting or changing an antidepressant should be watched for shifts in mood or behavior.
Crisis resources and the specific signs that mean you should get help right away are gathered in the closing block below, so you know exactly where to turn.
No, not in the way drugs like opioids are. There's no evidence of drug-seeking behavior with Anafranil. It does cause physical dependence, so stopping it suddenly can bring withdrawal, which is why a taper is recommended.
For many people, symptoms start within days and ease over one to two weeks. In published case reports, mild flu-like symptoms cleared in about three days. Timing depends on your dose and how long you took the drug, and there's no official fixed schedule.
You shouldn't. Clomipramine should be tapered gradually with monitoring, because abrupt stops drive the strongest withdrawal symptoms and can mask a returning OCD or depression.
A slow, prescriber-led taper is the main tool. Supportive care helps with the rest: steady sleep, regular meals, light activity, and therapy. There's no FDA-approved drug that treats discontinuation syndrome itself, so mild symptoms are managed much like a passing flu.
Some people report brief electric-shock sensations when stopping antidepressants. They aren't listed in the FDA clomipramine label, so consider them commonly reported rather than formally documented for this drug. Mention them to your prescriber if they happen.
Yes. Stopping can worsen psychiatric symptoms, so the OCD or depression clomipramine was treating may resurface. Telling a true return of the condition apart from short-term withdrawal is a clinical call worth making with your prescriber.
You don't have to figure this out alone. Compare treatment options and coverage in one place.
Search for CareReach Recovere helps people across the country find clomipramine and antidepressant treatment that fits their needs and budget. Search by what matters to you, then take the next step when you’re ready.
Get medical help right away, rather than waiting, for any of these: new or worsening thoughts of suicide or self-harm; severe agitation, panic, or a sharp drop in mood; seizures, an irregular or racing heartbeat, or confusion; or any symptom that feels dangerous or rapidly worse.
If you or someone else is in danger or thinking about suicide, call or text the 988 Suicide and Crisis Lifeline at 988, or call 911 in an emergency. The 988 Suicide and Crisis Lifeline is free and available 24/7.
For free, confidential help finding treatment, contact SAMHSA's National Helpline at 1-800-662-HELP (4357), or visit the SAMHSA National Helpline.
Medical disclaimer: This content is for general information and is not a substitute for professional medical advice, diagnosis, or treatment. Never stop or change clomipramine without talking to your prescriber. Always seek the advice of a qualified health provider with any questions about a medical condition or medication.
I am a professional writer, mainly in the fields of mental health, addiction, and living in recovery. I attempt to stay on top of the latest news in the addiction and the mental health world and enjoy writing about these topics to break the stigma associated with them.
I am a professional writer, mainly in the fields of mental health, addiction, and living in recovery. I attempt to stay on top of the latest news in the addiction and the mental health world and enjoy writing about these topics to break the stigma associated with them.
If you or a loved one needs financial help for rehab, we’re here to support you.